Stock listing
Monte Rosa Therapeutics, Inc.
Selected listing: GLUE · NASDAQ · USD · US
Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE), Health Technology. Latest release Oct 2, 2026: Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule…
- Ticker
- NASDAQ:GLUE
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc. is a public company traded under the ticker GLUE in the American market. Monte Rosa focuses on developing innovative therapies to address unmet medical needs.
Latest news from Monte Rosa Therapeutics, Inc.
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 2, 2026
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 1, 2026
Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of ASCVD in Subjects with Elevated CVD Risk
September 30, 2026
Monte Rosa Therapeutics to Present Results of MRT-8102 GFORCE-1 Phase 1 Study in Subjects with Elevated Cardiovascular Disease Risk
September 30, 2026
Monte Rosa Therapeutics to Present Results of MRT-8102 GFORCE-1 Phase 1 Study in Subjects with Elevated Cardiovascular Disease Risk
September 29, 2026
Events
Replays
Monte Rosa Therapeutics, Inc. (GLUE) Q4 2024 Earnings Call
Thu, Mar 20, 2025 · 08:00 AM ET
Watch
Research Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc. company profile
View the public company page for Monte Rosa Therapeutics, Inc. on 6ix.
Monte Rosa Therapeutics, Inc. news
Read company news and market updates connected to Monte Rosa Therapeutics, Inc..
Monte Rosa Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Monte Rosa Therapeutics, Inc..